Lipid Nanoparticles as versatile tool for (intradermal) vaccine delivery
Lipid nanoparticles (LNPs) have become the gold standard for delivering mRNA and other nucleic acid therapies, enabling everything from COVID-19 vaccines to the next generation of personalized cancer treatments. But the story doesn’t end there.
Our latest white paper explores:
- How LNP technology has evolved beyond the pandemic
- Emerging therapeutic applications in oncology and infectious diseases
- The challenges of inflammation, tissue targeting, and scalability
- Why intradermal delivery may unlock more efficient, dose-sparing vaccination strategies
📖 Download the white paper and discover what’s next for LNP-enabled RNA delivery.